{
  "docId": "019de075-3207-70ec-93a8-5bb5ec3d9629",
  "docSlug": "951aacbbe982699d0f743a597a954ece",
  "documentTitle": "OKYO Pharma | Results Presentation Deck | 25 slides",
  "authorId": "okyo-pharma",
  "authorName": "OKYO Pharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 25,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "timeline",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3207-70ec-93a8-5bb5ec3d9629/5",
  "deckHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629",
  "deckJsonHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629.json",
  "deckAnchorHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "Pre-IND Meeting Held February 2022; FDA Concurs First-in-human Trial to be Phase 2",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6bebce22-67c9-452b-831e-c2a53184b1ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.38
      },
      "kind": "list",
      "text": "FDA Agrees on Pre-Specified Co-primary Endpoints (Signs and Symptoms) for Phase 2 Trial",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab9d0497-6741-4b9e-96d4-879e150d02ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.56
      },
      "kind": "list",
      "text": "IND on OK-101 to tread DED patients cleared by FDA in December 2022",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c8ad8b00-9bc9-44fb-a8ce-15334fcf4673",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.74
      },
      "kind": "list",
      "text": "OK-101 Phase 2 Trial Top-line Data Anticipated before End of 2023",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef1286b1-de78-4287-93ec-2c15b97f2b9b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "OK-101 Phase 2 Trial Start in DED Patients Announced on May 2, 2023",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e6e223a1-0a31-4946-a048-158936d4625a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "deb83ec7-5d3d-46b1-8efd-5e6c5f81f71b",
      "evidence": "Sequential milestones presented in chronological order",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}